Company
ViSci
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Vi-Sci’s innovative Eye-D technology treats glaucoma by the insertion of a sub-conjunctival implant, which releases the prescribed medication “Latanaprost”, in sustained release manner, eliminating the need to use eye drops, a daily challenge for the aged.
Loading relationship preview